During the past decade, LMC Clinical Research Inc. (Brampton) conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LMC Clinical Research Inc. (Brampton)" #1 sponsor was "LMC Diabetes & Endocrinology Ltd." with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Kowa Research Institute, Inc." with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LMC Clinical Research Inc. (Brampton)" #1 collaborator was "Abbott Diabetes Care" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "LMC Clinical Research Inc. (Brampton)" are "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Chronic Kidney Disease" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "LMC Clinical Research Inc. (Brampton)" in a lesser frequency.

Most popular intervention types in "LMC Clinical Research Inc. (Brampton)" are "Drug" (12 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "BI 456906" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMC Clinical Research Inc. (Brampton)" are 15 trials for "All" genders.

Currently, there are NaN active trials in "LMC Clinical Research Inc. (Brampton)". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in LMC Clinical Research Inc. (Brampton), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in LMC Clinical Research Inc. (Brampton), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".